Cargando…

An "unexpected" role for EMT transcription factors in hematological development and malignancy

The epithelial to mesenchymal transition (EMT) is a fundamental developmental process essential for normal embryonic development. It is also important during various pathogenic processes including fibrosis, wound healing and epithelial cancer cell metastasis and invasion. EMT is regulated by a varie...

Descripción completa

Detalles Bibliográficos
Autores principales: Radhakrishnan, Karthika, Truong, Lynda, Carmichael, Catherine L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435889/
https://www.ncbi.nlm.nih.gov/pubmed/37600794
http://dx.doi.org/10.3389/fimmu.2023.1207360
_version_ 1785092206442315776
author Radhakrishnan, Karthika
Truong, Lynda
Carmichael, Catherine L.
author_facet Radhakrishnan, Karthika
Truong, Lynda
Carmichael, Catherine L.
author_sort Radhakrishnan, Karthika
collection PubMed
description The epithelial to mesenchymal transition (EMT) is a fundamental developmental process essential for normal embryonic development. It is also important during various pathogenic processes including fibrosis, wound healing and epithelial cancer cell metastasis and invasion. EMT is regulated by a variety of cell signalling pathways, cell-cell interactions and microenvironmental cues, however the key drivers of EMT are transcription factors of the ZEB, TWIST and SNAIL families. Recently, novel and unexpected roles for these EMT transcription factors (EMT-TFs) during normal blood cell development have emerged, which appear to be largely independent of classical EMT processes. Furthermore, EMT-TFs have also begun to be implicated in the development and pathogenesis of malignant hematological diseases such as leukemia and lymphoma, and now present themselves or the pathways they regulate as possible new therapeutic targets within these malignancies. In this review, we discuss the ZEB, TWIST and SNAIL families of EMT-TFs, focusing on what is known about their normal roles during hematopoiesis as well as the emerging and “unexpected” contribution they play during development and progression of blood cancers.
format Online
Article
Text
id pubmed-10435889
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104358892023-08-19 An "unexpected" role for EMT transcription factors in hematological development and malignancy Radhakrishnan, Karthika Truong, Lynda Carmichael, Catherine L. Front Immunol Immunology The epithelial to mesenchymal transition (EMT) is a fundamental developmental process essential for normal embryonic development. It is also important during various pathogenic processes including fibrosis, wound healing and epithelial cancer cell metastasis and invasion. EMT is regulated by a variety of cell signalling pathways, cell-cell interactions and microenvironmental cues, however the key drivers of EMT are transcription factors of the ZEB, TWIST and SNAIL families. Recently, novel and unexpected roles for these EMT transcription factors (EMT-TFs) during normal blood cell development have emerged, which appear to be largely independent of classical EMT processes. Furthermore, EMT-TFs have also begun to be implicated in the development and pathogenesis of malignant hematological diseases such as leukemia and lymphoma, and now present themselves or the pathways they regulate as possible new therapeutic targets within these malignancies. In this review, we discuss the ZEB, TWIST and SNAIL families of EMT-TFs, focusing on what is known about their normal roles during hematopoiesis as well as the emerging and “unexpected” contribution they play during development and progression of blood cancers. Frontiers Media S.A. 2023-08-03 /pmc/articles/PMC10435889/ /pubmed/37600794 http://dx.doi.org/10.3389/fimmu.2023.1207360 Text en Copyright © 2023 Radhakrishnan, Truong and Carmichael https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Radhakrishnan, Karthika
Truong, Lynda
Carmichael, Catherine L.
An "unexpected" role for EMT transcription factors in hematological development and malignancy
title An "unexpected" role for EMT transcription factors in hematological development and malignancy
title_full An "unexpected" role for EMT transcription factors in hematological development and malignancy
title_fullStr An "unexpected" role for EMT transcription factors in hematological development and malignancy
title_full_unstemmed An "unexpected" role for EMT transcription factors in hematological development and malignancy
title_short An "unexpected" role for EMT transcription factors in hematological development and malignancy
title_sort "unexpected" role for emt transcription factors in hematological development and malignancy
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435889/
https://www.ncbi.nlm.nih.gov/pubmed/37600794
http://dx.doi.org/10.3389/fimmu.2023.1207360
work_keys_str_mv AT radhakrishnankarthika anunexpectedroleforemttranscriptionfactorsinhematologicaldevelopmentandmalignancy
AT truonglynda anunexpectedroleforemttranscriptionfactorsinhematologicaldevelopmentandmalignancy
AT carmichaelcatherinel anunexpectedroleforemttranscriptionfactorsinhematologicaldevelopmentandmalignancy
AT radhakrishnankarthika unexpectedroleforemttranscriptionfactorsinhematologicaldevelopmentandmalignancy
AT truonglynda unexpectedroleforemttranscriptionfactorsinhematologicaldevelopmentandmalignancy
AT carmichaelcatherinel unexpectedroleforemttranscriptionfactorsinhematologicaldevelopmentandmalignancy